Dr. Anish Koka

JANUARY 1, 2023

Myopericarditis is a now a well reported complication associated with Sars-Cov-2 (COVID-19) vaccinations. To add insult to injury, he contracted COVID 2 months after the second episode of pericarditis, but had no recurrence of the symptoms of pericarditis. The tragedy here is that this wasn’t a surprise.

COVID-19 52

COVID-19 Pericarditis Chest Pain Biomarkers 52

The British Journal of Cardiology

JUNE 11, 2024

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included.

COVID-19 40

COVID-19 Cardiovascular Disease Angina Chest Pain 40

Circulation

NOVEMBER 11, 2024

Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. A retrospective chart review was performed on 41 patients with COVID-19 on ECMO between March and October 2020.

COVID-19 40

COVID-19 Laboratory Biomarkers Echocardiogram 40

Open Heart

FEBRUARY 23, 2023

Background Long COVID is associated with multiple symptoms and impairment in multiple organs. Using cardiac MR (CMR), we investigated a 12-month trajectory of abnormalities in Long COVID. since first post-COVID-19 symptoms. Cardiac-related blood biomarkers could not identify CMR abnormalities in Long COVID.

COVID-19 52

COVID-19 Quality of Life Biomarkers Outcomes 52

DAIC

APRIL 9, 2024

Although they had no symptoms of heart failure or blockages in arteries carrying blood to the heart, they all had structural heart disease or abnormal cardiac biomarkers that classified them as having “pre-heart failure,” putting them at high risk for developing overt symptoms of the diagnosis.

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

IntroductionThe COVID-19 pandemic, starting in 2020, raised concerns about potential long-term health impacts, including its effects on cardiovascular health and related biomarkers.

COVID-19 52

COVID-19 Blood Pressure Cholesterol Biomarkers 52

Medical Xpress - Cardiology

AUGUST 19, 2024

Their point-of-care electrochemical biosensor prototype, which resembles a see-through lateral flow test for COVID-19, can measure levels of two biomarkers for heart failure in as little as 15 minutes from just a drop of saliva. So, a team of researchers aims to bring heart failure screening from the lab to the home.

Heart Failure 106

Heart Failure COVID-19 Biomarkers Research 106